Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05415293 · ClinicalTrials.gov registry record · NA
Commerical DHA Supplementation
A NA study, sponsored by University of New Mexico.
- Terminated
- Registry status
- NA
- Development phase
- 72
- Enrollment target
NCT05415293 is a NA study that was terminated before completion, run by University of New Mexico. The registered enrollment target is 72 participants.
The verdict
NCT05415293, a NA study, was terminated before completion, sponsored by University of New Mexico.
- TERMINATED
- Registry status
- NA
- Development phase
- 72 participants
- Enrollment target
Study Summary
The purpose of this study is to compare blood levels of women who take commericially available, low dose docosahexaenoic acid (DHA) dietary supplements in pregnancy with women who do not take supplements.
Interventions
- DIETARY_SUPPLEMENT Expecta 200mg DHA
- DIETARY_SUPPLEMENT Promise 275mg DHA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2011-05 |
| Est. Completion | 2011-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05415293
The ClinicalTrials.gov registry entry for NCT05415293 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of New Mexico, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Expecta 200mg DHA is the first listed.
NCT05415293 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05415293 about?
NCT05415293 is a clinical study titled "Commerical DHA Supplementation". The purpose of this study is to compare blood levels of women who take commericially available, low dose docosahexaenoic acid (DHA) dietary supplements in pregnancy with women who do not take supplements.
What is the current status of trial NCT05415293?
This trial is currently terminated. It is a NA study. The enrollment target is 72 participants. The study started on 2011-05. Estimated completion is 2011-05.
What interventions are being tested in trial NCT05415293?
The interventions under investigation include: Expecta 200mg DHA (DIETARY_SUPPLEMENT), Promise 275mg DHA (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05415293?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.